Fresenius Medical Care AG & Co. KGaA
FMS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $740,870 | $732,458 | $894,325 | $1,219,028 |
| Dep. & Amort. | $1,742,257 | $1,751,971 | $1,838,363 | $1,623,676 |
| Deferred Tax | -$72,672 | -$122,149 | -$41,471 | $67,259 |
| Stock-Based Comp. | $0 | $32,515 | $0 | $0 |
| Change in WC | $444,313 | $561,276 | -$128,067 | -$97,768 |
| Other Non-Cash | -$468,624 | -$327,270 | -$395,771 | -$322,697 |
| Operating Cash Flow | $2,386,144 | $2,628,801 | $2,167,379 | $2,489,498 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$699,358 | -$684,596 | -$723,988 | -$854,360 |
| Net Acquisitions | $606,683 | $136,999 | $1,028 | -$381,727 |
| Inv. Purchases | -$81,501 | -$102,363 | -$105,641 | -$129,081 |
| Inv. Sales/Matur. | $75,134 | $89,595 | $57,671 | $144,516 |
| Other Inv. Act. | $14,103 | $16,138 | $36,205 | $24,424 |
| Investing Cash Flow | -$84,939 | -$544,227 | -$734,725 | -$1,196,228 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,905,149 | -$1,189,793 | -$1,118,007 | -$358,903 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | -$349,162 | -$328,623 | -$395,556 | -$392,455 |
| Other Fin. Act. | -$314,989 | -$340,113 | -$103,797 | -$273,024 |
| Financing Cash Flow | -$2,569,300 | -$1,858,529 | -$1,617,360 | -$1,024,382 |
| Forex Effect | $26,198 | -$72,607 | -$23,162 | $131,228 |
| Net Chg. in Cash | -$241,897 | $153,438 | -$207,868 | $400,116 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,427,225 | $1,273,787 | $1,481,655 | $1,081,539 |
| End Cash | $1,185,328 | $1,427,225 | $1,273,787 | $1,481,655 |
| Free Cash Flow | $1,686,786 | $1,944,205 | $1,443,391 | $1,635,138 |